Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
252.00    -1.80 (-0.71%)
Bid:
252.20
Ask:
252.80
Spread: 0.60 (0.238%)
Market Cap: £635.01m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Trading Statement

19 May 2025 07:00

RNS Number : 0818J
Genuit Group PLC
19 May 2025
 

19 May 2025

Genuit Group plc

Trading in line with expectations; full year outlook maintained

Genuit Group plc ('Genuit', the 'Company' or the 'Group'), the UK's largest provider of sustainable water, climate and ventilation solutions for the built environment, today issues an update on trading for the four months ended 30 April 2025 ahead of its Annual General Meeting ("AGM"), which takes place at 13:00hrs (BST) today at 4 Victoria Place, Holbeck, Leeds LS11 5AE.

 

Joe Vorih, Chief Executive Officer, commented:

"We maintain our outlook for the full year with the Group trading in line with expectations during the first four months of the year and the UK market showing some encouraging signs of recovery.

Each of our Business Units has delivered organic sales growth for the first four months and we have secured some positive share gains in a competitive market. We are also making strong progress on the continued deployment of the Genuit Business System to drive productivity.

Whilst we recognise the broader macroeconomic backdrop remains uncertain, Genuit is not directly exposed to changes in trade tariffs and is well positioned to navigate this near-term environment. Over the medium-term, we remain confident in out-performing the market due to our strong exposure to sustainability-linked growth drivers."

 

Current Trading and Outlook

Group revenue for the four months ended 30 April 2025 was £199.3m (2024: £183.7m), representing a year-on-year increase of 8.5% (5.3% on a like-for-like basis) albeit against a low comparator.

 

Climate Management Solutions (c.31%* of Group revenue) - revenue was 9.0% higher year-on-year (5.2% on a like-for-like basis), with continued strong growth in residential ventilation and improving commercial sales at Nuaire. Adey's water filtration business saw revenues that were broadly flat year-on-year. Underfloor heating solution sales at Nu-Heat and Omnie were more subdued in the context of continuing softness in the RMI market, but order intake showed signs of improvement in April.

Water Management Solutions (c.28%* of Group revenue) - revenue was 9.6% higher year-on-year (1.8% on a like-for-like basis), with demand for stormwater attenuation solutions increasing in the context of drier Spring weather. The Sky Garden blue-green roof business has seen strong order intake supporting growth forecasts for the year. Good progress is being made implementing the Genuit Business System which is forecast to positively impact margin in the second half.

Sustainable Building Solutions (c.40%* of Group revenue) - revenue was 8.2% higher year-on-year on a reported and like-for-like basis, including market share gains following the exit of a competitor in the UK drainage market. Whilst volumes are still historically low, new housebuilding is showing positive signs of recovery. RMI and commercial markets remain more challenging but the Business Unit is making strong progress with added value solutions and demand related to modern methods of construction.

 

Whilst some dilution of Group margins is anticipated for the first half of the year due to increases in National Insurance and the minimum wage, the Group is focussed on mitigating this impact, through a combination of productivity gains and balanced cost and price management.

 

The Group continues to focus on securing further market share gains through organic growth initiatives and new product introduction. In parallel, strong progress is being made on deploying the Genuit Business System to further increase productivity. With a strong balance sheet, the Group also continues to cultivate the acquisition pipeline, with a focus on strategic bolt-on opportunities.

 

Notice of Interim Results

The Company will report its interim results for the six months ending 30 June 2025 on 12 August 2025.

* The remaining c.1% of Group revenue consists of Polypipe Italia, which is not part of our strategic Business Units.

 

 

Enquiries:

Joe Vorih, Chief Executive Officer

Tim Pullen, Chief Financial Officer

+44 (0) 1138 315315

 

Headland Consultancy:

Matt Denham

Telephone: 020 3805 4822

Email: genuit@headlandconsultancy.com

Chloe Francklin

 

About Genuit Group plc

Genuit Group plc is the UK's largest provider of sustainable water, climate and ventilation products for the built environment. Genuit's solutions allow customers to mitigate and adapt to the effects of climate change and meet evolving sustainability regulations and targets.

The Group is divided into three Business Units, each of which addresses specific challenges in the built environment:

· Climate Management Solutions - Addressing the drivers for low carbon heating and cooling, and clean and healthy air ventilation.

· Water Management Solutions - Driving climate adaptation and resilience through integrated surface and drainage solutions.

· Sustainable Building Solutions - Providing a range of construction solutions to reduce the carbon content of the built environment.

Across these Business Units, Genuit's brands are some of the most well-established and innovative in the industry, including Polypipe, Nuaire and Adey.

The Group primarily serves the UK and European building and construction markets with a presence in Italy and the Netherlands and sells to specific niches in the rest of the world.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFMFIMEISEDI
Date   Source Headline
10th Jun 20244:32 pmRNSHolding(s) in Company
28th May 20242:14 pmRNSResult of AGM
28th May 20247:00 amRNSTrading Update
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding
17th Mar 202311:28 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
8th Mar 20234:26 pmRNSBoard updates
28th Feb 20235:55 pmRNSHolding(s) in Company
27th Feb 20239:36 amRNSDirectorate Change
31st Jan 202310:22 amRNSDirector Declaration
26th Jan 20236:27 pmRNSHolding(s) in Company
28th Nov 20224:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.